Zobrazeno 1 - 10
of 133
pro vyhledávání: ''
Autor:
Babak PeyroShabany, Mansoureh Dehghani, Seyed Alireza Javadinia, Danial Fazilat-Panah, Pejman Porouhan, Farbod Hatami, James S Welsh, Maryam Nabavifard, Mona Ariamanesh, Mohammad Fereidouni
Publikováno v:
Cancer Investigation
article-version (VoR) Version of Record
article-version (VoR) Version of Record
ObjectivePatients with malignancy suffer from a compromised immune system due to either the effects of malignancies or treatments. Cancer patients are at higher risk of different infections particularly SARS-CoV2 and usually produce weaker response t
Autor:
Beatriz Castelo, Jacobo Rogado, Paula Jiménez-Fonseca, Eva Martínez de Castro, Raquel Hernández, Oliver Higuera, Alberto Carmona-Bayonas, Ismael Ghanem, María del Mar Muñoz, Caterina Calderon
Publikováno v:
Cancer Investigation. 39:589-596
The aim of this study was to compare physicians' and patients' estimates of risk of relapse and toxicity. A prospective, cross-sectional, multicenter study including 735 patients with cancer and 29 oncologists. Physicians' appraisals of risk of relap
Publikováno v:
Cancer Investigation. 39:582-588
Proton therapy (PT) is an important component of therapy for select cancers, but no formal study of geospatial access to PT has been conducted to date. Population data for 320.7 million people in 32,644 zip codes were analyzed. Median travel time was
Autor:
Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
Publikováno v:
Cancer Investigation. 39:473-481
Aim: The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment. Method: Retrospective analysis of T-DM1 results of human epidermal grow
Autor:
Danial Fazilat-Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, Maedeh Alsadat Fatemi, Nahid Ahmadi, Davoud Jahansouz, Mohsen Tabasi, Seyed Alireza Javadinia, Maryam Joudi, Hadi Harati, Fahimeh Attarian, Farzad Taghizadeh-Hesary
Publikováno v:
Cancer investigation. 40(6)
To determine the clinical characteristics and outcomes of COVID-19 in a large cohort of new cancer patients referred to an oncology clinic in the north of Iran.During the 20-month COVID-19 pandemic, new cancer patients were followed-up. Demographic,
Autor:
Keisuke Monji, Ario Takeuchi, Ryosuke Takahashi, Junichi Inokuchi, Satoshi Kobayashi, Masatoshi Eto, Takashi Matsumoto, Masaki Shiota, Asako Machidori, Akira Yokomizo, Eiji Kashiwagi, Ken ichiro Shiga, Takuya Yamashita
Publikováno v:
Cancer Investigation. 39:251-256
We investigated the efficacy and safety profiles of 4-weekly docetaxel for castration-resistant prostate cancer. Patients treated with ≥2 courses of docetaxel chemotherapy (median, 70 mg/m2) betwee...
Autor:
Yoshiki Negi, Yasuhiro Nakajima, Takashi Yokoi, Kozo Kuribayashi, Takashi Kijima, Toshiyuki Minami, Ryo Takahashi, Hirotoshi Ishigaki, Kazuhiro Kitajima, Hiroshi Doi, Akio Tada
Publikováno v:
Cancer Investigation. 38:356-364
Pleural effusion adenosine deaminase (ADA) levels are elevated in various diseases. We investigated whether pleural effusion ADA levels differ among patients with malignant pleural mesothelioma (MPM), lung cancer (LC), and benign diseases, including
Autor:
Vanessa Davies, Ioannis A. Voutsadakis
Publikováno v:
Cancer Investigation. 38:94-101
Background: Amplification of the centromeric region of chromosome 17 (CEP17) as measured by In Situ Hybridization (ISH) of the CEP17 probe is used clinically as part of the ISH assay for HER2 statu...
Autor:
Rebecca M. Schwartz, Emanuela Taioli, Kristin Bevilacqua, Bian Liu, Katherine A. Ornstein, Naomi Alpert
Publikováno v:
Cancer Investigation. 37:299-310
Age-related decreases in Quality of Life (QoL) are often compounded by comorbidities, including cancer. This study aimed to examine QoL changes before and after a new cancer diagnosis using data from the National Health and Aging Trend Study (NHATS),
Autor:
Kelsey Maguire, Andriy Derkach, Nandini Umesh Yadav, Jeffrey S. Groeger, Petros Grivas, Ali Raza Khaki, Adam Klotz, Margaret M. Madeleine, Esther Babady, Lisa Tachiki, Sandy Simcha Nath, Afia Babar, Gary H. Lyman, Ying Taur, Justin Jee, Sanjay Chawla, Molly Maloy, Rocio Perez-Johnston, Daniel J. Henning, H. Laura Aaltonen
Publikováno v:
Cancer investigation. 40(1)
Our goal was to identify discrete clinical characteristics associated with safe discharge from an emergency department/urgent care for patients with a history of cancer and concurrent COVID-19 infection during the SARS-CoV-2 pandemic and prior to wid